<DOC>
	<DOCNO>NCT01492608</DOCNO>
	<brief_summary>The purpose study ass whether magnesium sulphate woman risk preterm birth protect child cerebral palsy . The result randomise controlled trial add previous meta-analysis obtain firm evidence magnesium sulphate neuroprotector , determine whether used standard therapy woman preterm birth .</brief_summary>
	<brief_title>Magnesium Sulphate Preterm Birth ( MASP Study )</brief_title>
	<detailed_description>Cerebral palsy consist chronic non-progressive clinical syndrome characterize motor postural dysfunction . In affected infant , voluntary movement become difficult limited , although clinical expression may change time , disability accompany major personal socioeconomic burden . Preterm infant increase risk cerebral palsy , inversely correlate gestational age birth . Previous study indicate magnesium sulphate may neuroprotective preterm infant , drug give woman prior preterm birth . However , benefit antenatal magnesium sulphate recently question Trial Sequential Analysis ( TSA ) , statistical method adjusts risk random error publish meta-analyses . TSA demonstrate additional data need accept magnesium sulphate evidence base therapy woman preterm labour . Therefore close gap perform new randomised clinical trial ( RCT ) , aim ass whether magnesium sulphate woman prior preterm birth protect child cerebral palsy . The RCT individually power detect significant difference magnesium placebo . Instead , trial complete , result add previous meta-analysis obtain firm evidence magnesium sulphate neuroprotector , determine whether used standard therapy woman preterm birth . From Denmark 500 eligible woman , risk preterm birth 24 32 week gestation , randomise receive either intravenous magnesium sulphate placebo . Randomisation perform blind computer generate random numbers.The child follow 18 month age forward standardized developmental questionnaire parent . If sign cerebral palsy suspect questionnaire , child examine neurologically .</detailed_description>
	<mesh_term>Cerebral Palsy</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>Gestational age 24+031+6 week Singletons twin Preterm rupture membranes 24+031+6 week contraction expect birth within 224 hour Preterm contraction expect birth within 224 hour Anticipated delivery within 224 hour reason ( due example fetal growth restriction ) Age 18 year inclusion Major fetal abnormality fetal death . ( Major fetal abnormality chromosome abnormality , myelomeningocele cerebral abnormality give neurological handicap ) Maternal contraindication magnesium sulphate ( example pulmonary disorder , kidney disease creatinin &gt; 100 , myasthenia gravis , atrioventricular block , treatment aminoglycosides ) Magnesium sulphate give reason ( example prevention eclampsia ) Patients speak understand Danish Allergies towards magnesium sulphate</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>magnesium sulphate</keyword>
	<keyword>preterm birth</keyword>
	<keyword>cerebral palsy</keyword>
</DOC>